Archive

Alantra advises Sangamo Therapeutics on the acquisition of TxCell

30 November

Alantra, a global investment banking and asset management company focused on the mid-market segment, has acted as sole M&A advisor to Sangamo Therapeutics, a leading development company of technologies for gene-based therapies, on the acquisition of TxCell, a French listed biotech specialized in CAR-Tregs. The transaction was structured in two parts: an off-market block acquisition […]

Alantra advises Alpha Bank on the sale of Portfolio Mercury, c.EUR 2bn non-performing unsecured consumer, small business and personal insolvency loan portfolio in Greece

29 November

Athens, November 29, 2018 – Alantra portfolio advisory team (“Alantra CPA”) is pleased to announce its role as advisor to Alpha Bank, one of Greece’s four systemic banks, on the signing of a transaction whereby Hoist Finance has entered into an agreement to acquire a Greek unsecured non-performing loan portfolio with a total outstanding balance of […]

Alantra PE gana el premio de Private Equity Exchange al mejor fondo español de LBOs

22 November

La división de private equity de Alantra (“Alantra PE”) ha ganado el premio al mejor fondo español de LBOs durante la 9ª edición de los Private Equity Exchange Awards, que se celebraron en París el 21 de noviembre. El jurado estuvo compuesto por más de 80 expertos de alto nivel, incluidos LPs y Asset Managers, […]

ICIS: M&A streak is all set to continue

20 November

Dr. Bernd Schneider, head of Chemicals & Polymers at Alantra explains the good health of the chemical sector in the M&A market at the ICIS Chemical Business Magazine. Click here to read the full article.

Alantra advises Visible Body on Strategic Investment by Capitala Group and Lineage Capital

19 November

BOSTON, November 19, 2018 –ALANTRA, a leading global middle-market investment bank and asset management firm, is pleased to announce that its client, Visible Body, creator of the world’s best-selling human anatomy app, has entered into a strategic partnership with Capitala Group and Lineage Capital. The deal closed on November 7, 2018 and the transaction value was […]

Alantra advised Quadriga Capital on the sale of Alicona Imaging to US-based Bruker Corporation

14 November

Frankfurt, November 14, 2018 – Alantra, a global investment banking and asset management company focused on the mid-market segment has advised funds advised by Quadriga Capital Private Equity Fund IV LP (“Quadriga Capital”) on the sale of Alicona Imaging GmbH (“Alicona”), a provider of high-resolution optical 3D metrology solutions, to Bruker Corporation (“Bruker”) for an […]

Alantra advises Branford Castle on the Sale of Canada Metal (Pacific) Ltd

12 November

BOSTON, November 13, 2018 –ALANTRA, a leading global middle-market investment bank and asset management firm, is pleased to announce that its client Branford Castle, Inc. (“Branford Castle”), a New York-based investor and affiliate of private equity manager Branford Castle Partners, LP, has sold its portfolio company Canada Metal (Pacific) Limited (“CMP” or the “Company”) to Ironbridge […]

Alantra advises Quadriga Capital on the sale of DOREA to Groupe Maisons de Famille

7 November

Berlin/Frankfurt/Paris, 7 November 2018 – Alantra, a global investment banking and asset management company focused on the mid-market segment has advised Dorea Beteiligung S.à r.l. on the sale of DOREA Holding GmbH (“DOREA”), a leading German nursing care operator, owned by funds advised by Quadriga Eigenkapitalberatung GmbH (“Quadriga”), to Groupe Maisons de Famille (“MdF”) for […]